Outsourced Drug Discovery Market Analysis (2019-2026)

1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

2. OUTSOURCED DRUG DISCOVERY MARKET ANALYSIS - (2019-2026) • Outsourced Drug Discovery Marketby Drug Type (Small Molecule Drugs and Large Molecule Drugs), by Services (Preclinical Developments, Target validation and Functional Informatics, Target Identification and Screening, Lead Identification and Candidate Optimization, and Others), by Application (Oncology, Ophthalmology, Hematology, Immunomodulation, Anti-Infective Drugs, Dermatology, Neurology, Cardiology, and Others), by End Users (Pharmaceutical and Biotechnological Companies, Contract research Organization, and  Contract Manufacturing Organization), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2019 - 2026

3. Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development.

4. Market Dynamics • New strategies adopted by key players related to outsourcing drug discovery is expected to drive growth of global outsourced drug discovery market. For instance, in June 2019, GlaxoSmithKline (GSK), a British drug manufacturing company collaborated with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LGR), in San Francisco. The new laboratory will investigate how gene mutations cause diseases, and also develop new technologies using CRISPR to rapidly accelerate the discovery of new medicines. • Furthermore, extension of partnership activities is expected to propel global outsourced drug discovery market growth. For instance, in March 2017, Charles River Laboratories (CRL) extended its partnership with Chiesi Farmaceutici. Under this partnership, Charles River Laboratories (CRL) extended its longstanding, strategic, integrated drug discovery program (Respiratory Program). The respiratory program is related to the preclinical drug development for treatment of respiratory diseases and rare diseases.

5. Key features of the study: • This report provides in-depth analysis of the outsourced drug discovery market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2019–2026), considering 2017, as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global outsourced drug discovery market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

6. Key players covered as a part of this study include, Aurigene Accelerating Discovery, Bioduro LLC, Charles River Laboratories (CRL), Chempartner, TCG Lifesciences, Evotec AG, Syngene International Ltd. Jubilant Biosys Ltd, Pharmaron Inc., Shanghai Medicilon, and Sundia Meditech Co. Ltd. • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics • The global outsourced drug discovery market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for anesthesia device market, research and consulting firms, new entrants, and financial analysts

7. Detailed Segmentation: • Global Outsourced Drug Discovery  Market, By Drug Type: • Small Molecule Drugs • Large Molecule Drugs • Global Outsourced Drug Discovery market, By Services: • Preclinical Development • Target Validation and Functional Informatics • Target Identification and Screening • Lead Identification and Candidate Optimization • Others

8. Global Outsourced Drug Discovery Market, By Application • Oncology • Ophthalmology • Hematology • Immunomodulation • Anti-Infective Drugs • Dermatology • Pulmonology • Cardiology • Others

9. Global Outsourced Drug Discovery market, By End User • Pharmaceutical and Biotechnological Companies • Contract Research Organization • Contract Manufacturing Organization

10. Global Outsourced Drug Discovery market, By Region: • North America • By Country: • U.S. • Canada • By Drug Type: • Small Molecule Drugs • Large Molecule Drugs

11. By Services: • Preclinical Development • Target Validation and Functional Informatics • Target Identification and Screening • Lead Identification and Candidate Optimization • Others

12. By End User • Pharmaceutical and Biotechnological Companies • Contract Research Organization • Contract Manufacturing Organization • By Application • Oncology • Ophthalmology • Hematology • Immunomodulation • Anti-Infective Drugs • Dermatology • Pulmonology • Cardiology • Others

13. By Drug Type: • Small Molecule Drugs • Large Molecule Drugs • By Services: • Preclinical Development • Target Validation and Functional Informatics • Target Identification and Screening • Lead Identification and Candidate Optimization • Others • Europe • By Country: • U.K. • Germany • Italy • Spain • France • Russia • Rest of Europe

14. By End User • Pharmaceutical and Biotechnological Companies • Contract Research Organization • Contract Manufacturing Organization • By Application • Oncology • Ophthalmology • Hematology • Immunomodulation • Anti-Infective Drugs • Dermatology • Pulmonology • Cardiology • Others

15. By Drug Type: • Small Molecule Drugs • Large Molecule Drugs • By Services: • Preclinical Development • Target Validation and Functional Informatics • Target Identification and Screening • Lead Identification and Candidate Optimization • Others • Asia Pacific • By Country: • Australia • India • China • Japan • ASEAN • South Korea • Rest of Asia Pacific

16. By End User • Pharmaceutical and Biotechnological Companies • Contract Research Organization • Contract Manufacturing Organization • Latin America • By Country: • Brazil • Mexico • Argentina • Rest of Latin America • By Application • Oncology • Ophthalmology • Hematology • Immunomodulation • Anti-Infective Drugs • Dermatology • Pulmonology • Cardiology • Others

17. By Application • Oncology • Ophthalmology • Hematology • Immunomodulation • Anti-Infective Drugs • Dermatology • Pulmonology • Cardiology • Others • By Drug Type: • Small Molecule Drugs • Large Molecule Drugs • By Services: • Preclinical Development • Target Validation and Functional Informatics • Target Identification and Screening • Lead Identification and Candidate Optimization • Others

18. By Drug Type: • Small Molecule Drugs • Large Molecule Drugs • By Services: • Preclinical Development • Target Validation and Functional Informatics • Target Identification and Screening • Lead Identification and Candidate Optimization • Others • By End User • Pharmaceutical and Biotechnological Companies • Contract Research Organization • Contract Manufacturing Organization • Middle East • By Country/Region: • GCC • Israel • Rest of Middle East

19. By End User • Pharmaceutical and Biotechnological Companies • Contract Research Organization • Contract Manufacturing Organization • By Application • Oncology • Ophthalmology • Hematology • Immunomodulation • Anti-Infective Drugs • Dermatology • Pulmonology • Cardiology • Others

20. By Services: • Preclinical Development • Target Validation and Functional Informatics • Target Identification and Screening • Lead Identification and Candidate Optimization • Others • Africa • By Country/Region: • South Africa • Central Africa • North Africa • By Drug Type: • Small Molecule Drugs • Large Molecule Drugs

21. By End User • Pharmaceutical and Biotechnological Companies • Contract Research Organization • Contract Manufacturing Organization • By Application • Oncology • Ophthalmology • Hematology • Immunomodulation • Anti-Infective Drugs • Dermatology • Pulmonology • Cardiology • Others

22. TCG Lifesciences • Evotec AG • Syngene International Ltd. • Jubilant Biosys Ltd. • Pharmaron Inc. • Shanghai Medicilon Inc. • Sundia Meditech Co. Ltd. • Company Profiles • Aurigene Accelerating Discovery,* • Company Overview • Product Portfolio • Financial Performance • Recent Highlights • Strategies • Bioduro LLC. • Charles River Laboratories (CRL)

23.  “*” marked represents similar segmentation in other categories in the respective section.

24. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference:https://www.coherentmarketinsights.com/market-insight/outsourced-drug-discovery-market-2847

25. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

26. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

27. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/